{"nct_id":"NCT02998476","title":"A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2017-03-02","start_date_type":"ACTUAL","primary_completion_date":"2019-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}